Clinical trials
Staging clinical trials
Below are recruiting staging clinical trials, each written for real people, not researchers. We’re tracking 1,854 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04631770Recruiting
Mediastinal node removal versus sparing nodes for early lung nodule
This trial compares two surgical approaches for people with a single small, noncancer-looking lung nodule (a GGN) that is diagnosed as very early lung cancer. It aims to see whether removing mediastinal lymph nodes—or leaving them alone—can lead to better outcomes with less harm.
Tianjin, Tianjin MunicipalityAges Any age - NCT06065982Recruiting
Study of a method for placing a dialysis catheter (PREDICT)
This study watches how well a certain method (percutaneous) works for placing a peritoneal dialysis (PD) catheter, which is a soft tube used for a type of kidney dialysis. By tracking patients’ experiences before and after the procedure, the study aims to improve care for people with kidney failure.
BrusselsAges 18 years+ - NCT06073418Recruiting
Diet, nutrition, and physical activity in early breast cancer
This study looks at the eating habits, nutrition knowledge, and physical activity of women with early-stage breast cancer. It aims to understand how these factors relate to your health and recovery after surgery.
Aviano, PordononeAges 18 years+ - NCT05241028RecruitingPhase 2
Adjuvant ensartinib for ALK-positive lung cancer after surgery
This trial studies whether taking ensartinib (a targeted pill) after lung cancer surgery can lower the chance the cancer comes back. It is for people with ALK-positive non-small cell lung cancer (NSCLC) whose cancer has been fully removed and who have recovered from treatment.
Shijiazhuang, HebeiAges 18–75 - NCT06080776RecruitingPhase 3
SH-1028 vs placebo for early-stage EGFR-mutated lung cancer
This trial tests a pill called SH-1028 (an EGFR-targeted drug) versus a placebo to see if it helps prevent lung cancer from coming back after surgery in people with EGFR-mutated NSCLC. You may be eligible if you had complete removal of stage II-IIIB NSCLC and your tumor has a specific EGFR mutation.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT02290145RecruitingPhase 2
Study of Cyclin D1–targeted chemotherapy before oral cancer surgery
This Phase 2 trial tests a chemotherapy plan given first (before surgery) for people with oral squamous cell carcinoma that has specific cancer markers and lymph node involvement. It aims to shrink or control the cancer so treatment after may work better.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT05939063Recruiting
Testing two surgery approaches for early left pancreatic cancer
This trial compares two ways of doing surgery in people with early, left-sided pancreatic cancer that can be removed. It may help find the approach with better outcomes while aiming to keep the operation safe and effective.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT06017284RecruitingPhase 3
Thalidomide for nausea in pancreatic cancer patients
This trial tests whether adding thalidomide to standard chemotherapy can help reduce nausea and vomiting in people with advanced pancreatic cancer. It is for patients who have not yet received any cancer treatment.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT05978648RecruitingPhase 2
Trilaciclib for early-stage HR-negative breast cancer after surgery
This trial tests if adding trilaciclib to standard chemotherapy after surgery can help people with hormone receptor-negative breast cancer. It aims to reduce side effects and improve treatment outcomes.
Guangzhou, GangdongAges 18 years+ - NCT06029504Recruiting
Optical-guided sentinel node biopsy for vulvar cancer staging
This trial tests a new optical method using a dye to find and remove the first lymph node (sentinel node) that cancer might spread to, to stage vulvar cancer more accurately. It's for patients with a smaller tumor (under 4 cm) that hasn't been treated in the groin area before.
CopenhagenAges 18 years+ - NCT04992780RecruitingPhase 2
Hypo-fractionated radiation versus standard radiation for lung cancer
This study compares two different radiation schedules for stage III non-small cell lung cancer, both combined with chemotherapy and immunotherapy. It aims to see whether giving radiation in a different way can work as well (or better) and be safe while treating the cancer.
Kansas City, KansasAges 18 years+ - NCT06167356Recruiting
Bladder cancer relapse and quality of life study after TURBT
This study tracks patients with early-stage bladder cancer after surgery (TURBT) to see how often the cancer returns and how it affects your daily life.
Milan, MIAges 18 years+ - NCT06167109Recruiting
NBI and MRI to guide radiation planning for one-sided nose cancer
This trial tests whether combining a special scope (NBI) with MRI scans can help doctors better target radiation therapy for a specific type of nose/throat cancer that affects only one side. It aims to make treatment more precise and reduce side effects.
Chongqing, Chongqing MunicipalityAges 18 years+ - NCT06161428Recruiting
Dye-guided lymph node biopsy for vulvar cancer
This trial tests a new way to find and remove the first lymph node that might contain cancer cells in women with large or recurrent vulvar cancer. It uses a special dye to guide the surgeon, which may help improve staging and reduce side effects.
CopenhagenAges 18 years+ - NCT06181396Recruiting
Timing of oxytocin in second stage of labor
This study looks at when oxytocin is started during the pushing phase of labor to understand if timing affects outcomes for the mother and baby.
HaifaAges 18 years+ - NCT03371407Recruiting
Study brain movement training in people with Parkinson’s
This study looks at how people with Parkinson’s adapt their movements and how their brain sensorimotor system works. It may help researchers improve understanding of Parkinson’s and refine movement-focused therapies.
MarseilleAges 18 years+ - NCT06192849RecruitingPhase 2
Furmonertinib after surgery for EGFR 20 insertion lung cancer
This trial tests a targeted pill (furmonertinib) to prevent your lung cancer from coming back after surgery. It is for people with a certain genetic change in their tumor (EGFR exon 20 insertion) and stage IB, II, or IIIA disease.
Chengdu, SichuanAges 18 years+ - NCT06189898Recruiting
Using scans to find radiation-sensitive esophageal cancer
This study tests whether a special imaging scan (functional imaging) can identify which esophageal cancers respond best to radiation. If you have stage II–IVA esophageal cancer and meet the health criteria, joining may help personalize your treatment.
BerlinAges 18 years+ - NCT06196190Recruiting
Study on HPV after cone biopsy for cervical cancer
This study looks at women with early-stage cervical cancer (stage IB2) or a pre-cancer called AIS. The goal is to see if testing for HPV after a cone biopsy can help predict if the cancer will come back. Your HPV test results will be tracked over time.
HaifaAges 18–85 - NCT06204484Recruiting
MRD-guided Chemo Timing for Early Colon Cancer
This trial is for people with early-stage colon cancer (stage II high-risk or stage III low-risk) that is not MSI-H. It uses a blood test (MRD) to see if you can safely delay or skip extra chemotherapy after surgery, based on whether the test finds any leftover cancer cells.
Guangzhou, GuangdongAges 18–70 - NCT05011487RecruitingPhase 2
Before-surgery osimertinib plus chemotherapy for EGFR lung cancer
This study tests whether giving osimertinib together with chemotherapy before surgery can shrink and control EGFR-mutant, stage III lung cancer so it can be fully removed. If it works, it may improve the chances that the cancer does not come back after surgery.
Guangzhou, GuangdongAges 18–75 - NCT06219746Recruiting
New imaging scan for high-risk prostate cancer staging
This trial tests a special type of scan (99mTc-MIP-1404 SPECT/CT) to see how well it can detect the spread of high-risk prostate cancer. It may help doctors better understand the stage of the disease before deciding on treatment.
Turku, Southwest FinlandAges 18 years+ - NCT06007261Recruiting
Testing a new microscope for lung cancer diagnosis
This study tests a new microscope that quickly analyzes lung tissue during a bronchoscopy or surgery. It may help doctors make faster, more accurate decisions about your care.
Nijmegen, GelderlandAges 18 years+ - NCT06241807RecruitingPhase 2
Camrelizumab plus chemo before surgery for stage III lung cancer
This trial tests adding the immunotherapy drug camrelizumab to standard chemotherapy before surgery for people with stage IIIA-IIIB non-small cell lung cancer. The goal is to see if this combination shrinks tumors more effectively before removal.
Jinan, ShandongAges 18–75
Hear when a new Staging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for staging?
- Yes. Clin2 currently lists 1,854 recruiting staging studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a staging trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a staging trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.